Eptifibatide 25021-0408
Product NDC
25021-0408- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 15, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA204693
Need to source Eptifibatide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eptifibatide | .75 mg/mL |
Drug Class
Platelet Aggregation Inhibitor [EPC]Decreased Platelet Aggregation [PE]Platelet Aggregation Inhibitor [EPC]
Packaging Options(1)
1 VIAL in 1 CARTON (25021-408-51) / 100 mL in 1 VIAL